Business ❯Pharmaceutical Industry ❯Drug Development

Weight Loss Drugs

Roche CT-388 Semaglutide Competition Market Trends Eli Lilly's Zepbound

Roche's Experimental Obesity Drug CT-388 Shows Significant Weight Loss in Early Trials

Eli Lilly Faces Zepbound Shortage, Impacting Weight Loss and Diabetes Patients